Recommended Pages at fiercebiotech.com
Ex-Sanofi chemist locked up after theft - FierceBiotech
fiercebiotech.com — “After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents.” View full resource at fiercebiotech.com
Most Recently Shared on May 8, 2012 at 4:17 pm By:
Ex-Sanofi chemist locked up after theft http://t.co/mjqsh2Jk $SNY
Savient hammered after hedge fund claims it's bankrupt - FierceBiotech
fiercebiotech.com — “Savient hammered after hedge fund claims it's bankrupt - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 2, 2012 at 12:23 pm By:
John Carroll Health Communicator
RT @FierceBiotech: Savient hammered after #hedgefund claims it's bankrupt http://t.co/pczGHF5w $SVNT #biotech #pharma #SEC
Abbott tries to throw up roadblock to Humira biosim - FierceBiotech
fiercebiotech.com — “Abbott tries to throw up roadblock to Humira biosim - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 4:37 pm By:
Abbott tries to throw up roadblock to Humira biosim http://t.co/SZdaeAiV $ABT #biosimilars #FDA #biotech #pharma
Pfizer turns to late-stage pipeline to make up for Lipitor crash - FierceBiotech
fiercebiotech.com — “Pfizer turns to late-stage pipeline to make up for Lipitor crash - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 3:47 pm By:
Pfizer turns to late-stage pipeline to make up for #Lipitor crash http://t.co/2SCeBslk $PFE @Pfizer_news #pharma
Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls - FierceBiotech
fiercebiotech.com — “Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 3:18 pm By:
John Carroll Health Communicator
RT @FierceBiotech: Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls http://t.co/pHJuUBKB $NVO @NovoNordisk #biotech
AstraZeneca's new iMed R&D team forges first pact with Axerion - FierceBiotech
fiercebiotech.com — “AstraZeneca's new iMed R&D team forges first pact with Axerion - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 2:40 pm By:
John Carroll Health Communicator
AZ's new iMed R&D team forges first pact with Axerion - #biotech http://t.co/xuPEWgOH
GSK development team tackles a new drug class at Yale - FierceBiotech
fiercebiotech.com — “GSK development team tackles a new drug class at Yale - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 1:59 pm By:
. @GSK development team tackles a new drug class @Yale http://t.co/J354DRgU #biotech $GSK #partnerships #pharma
Supernus IPO spotlights perils, potential of going public - FierceBiotech
fiercebiotech.com — “Supernus IPO spotlights perils, potential of going public - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 1:18 pm By:
Supernus #IPO spotlights perils, potential of going public http://t.co/NGCQKDLI #biotech $SUPN HT @ldtimmerman
Targacept slashes staff by half in wake of PhIII disaster - FierceBiotech
fiercebiotech.com — “Targacept slashes staff by half in wake of PhIII disaster - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 25, 2012 at 2:11 pm By:
Paul W. Thomas Health Communicator
RT @fiercebiotech: Targacept slashes staff by half in wake of PhIII disaster http://t.co/W17V462P $TRGT #depression
Crucell and Royal DSM pull the plug on biosimilar JV - FierceBiotech
fiercebiotech.com — “Crucell and Royal DSM pull the plug on biosimilar JV - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 18, 2012 at 11:56 am By:
Exclusive: Crucell and Royal DSM pull the plug on #biosimilar JV http://t.co/YttZyDDX by @JohnCFierce #biotech $BIIB
AstraZeneca scouts new drug deals to silence a chorus of critics - FierceBiotech
fiercebiotech.com — “AstraZeneca scouts new drug deals to silence a chorus of critics - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 4, 2012 at 12:24 pm By:
John Carroll Health Communicator
AstraZeneca scouts new drug deals to silence a chorus of critics. #biotech http://t.co/6KVAMjSB
OvaScience grabs $37M B round for fertility treatments - FierceBiotech
fiercebiotech.com — “OvaScience grabs $37M B round for fertility treatments - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 4, 2012 at 11:07 am By:
My story abt OvaScience's $37M #VC round 4 fertility treatments. Sirtris vets tackle aging from a new angle: http://t.co/X1cB03Wg #biotech
Google contributes to $14M round for fast-growing Adimab - FierceBiotech
fiercebiotech.com — “Google contributes to $14M round for fast-growing Adimab - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 3, 2012 at 2:26 pm By:
John Carroll Health Communicator
Google contributes to $14M round for fast-growing Adimab: Bought a building - #biotech http://t.co/3v1zaKBt
Stemline bets $50M IPO on a pair of cancer stem cell treatments - FierceBiotech
fiercebiotech.com — “Stemline bets $50M IPO on a pair of cancer stem cell treatments - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 3, 2012 at 1:31 pm By:
John Carroll Health Communicator
RT @FierceBiotech: Stemline bets $50M #IPO on a pair of #cancer stem cell treatments http://t.co/2gQvV0tP #biotech
Bayer bolsters blockbuster case for regorafenib with new PhIII data - FierceBiotech
fiercebiotech.com — “Bayer bolsters blockbuster case for regorafenib with new PhIII data - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 3, 2012 at 12:40 pm By:
John Carroll Health Communicator
Bayer bolsters blockbuster case for regorafenib with new PhIII data (GIST): http://t.co/K36PicaH
